References
Maliqueo M, Lara HE, Sánchez F, Echiburú B, Crisosto N, Sir-Petermann T (2013) Placental steroidogenesis in pregnant women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 166(2):151–155
Segal S, Elmadjian M, Takeshige T, Karp S, Mercado R, Rivnay B (2010) Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance. Reprod Biomed Online 20(5):675–680
Karsli MF, Gultekin IB, Cakmak B, Yeral MI, Seckin KD, Alt Nboga O, Kucukozkan T (2014) Do we need readjustment of the biochemical parameters in first trimester combined aneuploidy screening test in women with polycystic ovary syndrome? Prenat Diagn 34(11):1073–1076
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
The manuscript does not require ethics standards.
Informed consent
The manuscript does not require informed consent.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Korkmaz, V., Kurdoglu, Z. & Ergun, Y. Should we change our mind about second trimester biochemical aneuploidy screening markers of patients with polycystic ovary syndrome?. J Endocrinol Invest 38, 1383–1384 (2015). https://doi.org/10.1007/s40618-015-0329-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-015-0329-0